Aussie Share Market Hits 10-Month Peak as Rio Shares Skyrocket

the Australian share market, a true force to be reckoned with, is scaling heights not seen since February 10. It’s a story of materials and energy stocks uniting to propel this benchmark to astonishing levels.

As the final bell chimed, the S&P/ASX200 showed its muscle, gaining a solid 0.8 per cent, a mighty 62.7 points, marking a breathtaking 7489.1. Not to be outdone, the broader All Ordinaries index soared, a triumphant 0.9 per cent, reaching a staggering 7715.9. It’s like witnessing the crescendo of a symphony in financial form.

And if that’s not impressive enough, the Australian dollar, often affectionately known as the “Aussie,” flexed its economic biceps, commanding a robust US 67.17c. Since October, this “Aussie” has boldly surged by a remarkable US 4c against the evergreen greenback.

In the midst of all this excitement, let’s not forget the Reserve Bank’s little tease, hinting at the possibility of raising the cash rate to 4.6 per cent at the December 5 meeting, only to hold the line. It’s a narrative that keeps us all on the edge of our seats, akin to a suspenseful Don Draper ad campaign.

Tim Waterer, the chief market analyst at KCM Trade, quipped, “The central bank doesn’t seem in a rush to raise rates again,” offering solace to the market. It’s like a well-crafted plot twist in the financial saga.

While the market eagerly awaits the upcoming quarterly inflation data on January 31, the latest data flows suggest that the Reserve Bank might just be done with its tightening cycle. It’s akin to Russell Brand’s penchant for unpredictability.

Now, let’s venture into the commodities arena. ASX-listed energy stocks, fueled by a two per cent surge in crude oil prices, ascended by a solid one per cent. Fear of supply disruptions ignited after Yemen-based Houthi rebels wreaked havoc in the Red Sea. The heavyweight, Woodside, added 1.7 per cent to $31.01, a performance worthy of the big screen.

In the materials sector, where mergers are the name of the game, iron ore miners shrugged off a dip in commodity prices, with Rio Tinto shares leaping by 0.7 per cent to a record high of $134.24. Meanwhile, Fortescue made its own mark, reaching a record high of $28.18 before settling at $28.09, a testament to the art of financial strategy.

In the world of corporate news, Origin Energy seized the spotlight, increasing its stake in British renewable energy group Octopus Energy with a significant $530 million investment. Shares for the local energy retailer surged by a formidable 3.2 per cent to $8.28, showcasing a masterful power play.

Over in the realm of lithium, Australian lithium chemicals producer Allkem embraced a $10.6 billion merger offer from U.S. giant Livent, poised to become the world’s third-largest producer of this precious commodity. Despite the approval, shares dipped 0.6 per cent to $10.59, illustrating the intricacies of high-stakes finance.

AGL Energy took center stage, climbing by 0.6 per cent to $9.14, announcing a final investment decision to develop a 500MW battery at its Hunter Energy Hub in NSW, once the site of the iconic Liddell coal-fired power station. It’s like a phoenix rising from the ashes, reflecting resilience and vision.

Enter Azure Minerals, scaling new heights by climbing 1.7 per cent to $3.69, following the revelation of a revised takeover offer worth $3.70 a share from Chile’s SQM and Gina Rinehart’s Hancock Prospecting. The duo had previously offered the lithium miner $3.52 per share, a classic display of corporate prowess.

And last but certainly not least, Telix Pharmaceuticals experienced a surge of 2.4 per cent to $9.79, driven by the submission of a licensing application to the U.S. Food and Drug Administration to advance an imaging agent for kidney cancer treatment. It’s akin to a medical marvel in the making, reminiscent of the heroes of Wall Street.